Introduction: Interleukin-17 is a pro-inflammatory cytokine with a wide range of protective and destructive effects in periodontitis. The role of IL-23 is stabilisation and expansion of Th-17. The aim of this study was to assess whether patients with aggressive and chronic periodontitis exhibit different gingival crevicular fluid (GCF) concentrations of IL-17 and IL-23 compared with clinically healthy subjects.
Material and methods: GCF samples were obtained from 32 patients: 10 with chronic periodontitis (CP), 12 with aggressive periodontitis (AgP), and 10 healthy controls (HC). IL-23 and IL-17 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Comparison of study groups was performed with ANOVA and Tukey HSD tests. Spearman’s correlation coefficient was used to assess correlations between the variables.
Results: IL-17 concentration was significantly higher in the healthy group compared to the AgP and CP groups (p < 0.001), but there were no significant differences between the CP and AgP groups. IL-23 levels in the healthy group were significantly higher than that in the AgP group (p < 0.001). Cytokine concentrations did not correlate significantly with probing depths and clinical attachment levels.
Conclusions: Gingival crevicular fluid concentrations of IL-17 and IL-23 were significantly higher in the healthy group compared to periodontitis groups.
REFERENCES(35)
1.
Albandar JM (2014): Aggressive periodontitis: case definition and diagnostic criteria. Periodontology 65: 13-26.
Duarte P, Bastos M, Fermiano D, et al. (2015): Do subjects with aggressive and chronic periodontitis exhibit a different cytokine/chemokine profile in the gingival crevicular fluid? A systematic review. J Periodont Res 50: 18-27.
Shaker OG, Ghallab NA (2012): IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection. Mediators Inflamm. doi: http://dx.doi.org/10.1155/2012....
Cifcibasi E, Koyuncuoglu C, Ciblak M, et al. (2015): Evaluation of local and systemic levels of interleukin-17, interleukin-23, and myeloperoxidase in response to periodontal therapy in patients with generalized aggressive periodontitis. Inflammation 38: 1959-1968.
Gaffen S, Hajishengallis G (2008): A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.
Isaza-Guzmán D, Cardona-Vélez N, Gaviria-Correa D, et al. (2015): Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis. Arch Oral Biol 60: 91-99.
Khader SA, Gaffen SL, Kolls JK (2009): Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2: 403-411.
Kotake S, Yago T, Kawamoto M, et al. (2012): Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial ‘human osteoclastology’. J Bone Miner Metab 30: 125-135.
Vernal R, Dutzan N, Chaparro A, et al. (2005): Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Periodontol 32: 383-389.
Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, et al. (2012): Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res 47: 525-531.
Ay ZY, Yilmaz G, Özdem M, et al. (2012): The gingival crevicular fluid levels of interleukin-11 and interleukin-17 in patients with aggressive periodontitis. J Periodontol 83: 1425-1431.
Cheng WC, Hughes FJ, Taams LS (2014): The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol 2014: 541-549.
Duarte PM, da Rocha M, Sampaio E, et al. (2010): Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol 81: 1056-1063.
Verreck FA, de Boer T, Langenberg DM, et al. (2004): Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria. Proc Nat Acad Sci USA 101: 4560-4565.
Szkaradkiewicz A, Karpinski T, Zeidler A, et al. (2011): Protective effect of oral lactobacilli in pathogenesis of chronic periodontitis. Journal Physiol Pharmacol 62: 685-689.
Lamster IB, Novak MJ (1992): Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 3: 31-60.
Friedmann A, Ozmeric N, Bernimoulin J-P, et al. (2014): Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery. Cent Eur J Immunol 39: 508-517.
Yetkin Ay Z, Sütçü R, Uskun E, et al. (2009): The impact of the IL-11: IL-17 ratio on the chronic periodontitis pathogenesis: a preliminary report. Oral Dis 15: 93-99.
Lester SR, Bain JL, Johnson RB, et al. (2007): Gingival concentrations of interleukin-23 and-17 at healthy sites and at sites of clinical attachment loss. J Periodontol 78: 1545-1550.
Azman R, Lappin DF, MacPherson A, et al. (2014): Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity. Inflamm Res 63: 1001-1012.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.